Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Racadot

Showing results (331-340 of 381) with videos related to

Pageof 39
Sort By:
Clinical and Translational Radiation Oncology|June 17, 2026
Defining physician acceptance of radiosensitivity testing for guiding therapeutic interventions in head and neck cancer: A Delphi consensus studyJuliette Thariat, Arnaud Beddok, Sébastien Salas, et al.
Clinical Nutrition (Edinburgh, Scotland)|July 16, 2013
Immunonutrition improves functional capacities in head and neck and esophageal cancer patients undergoing radiochemotherapy: a randomized clinical trialM-P Vasson, J Talvas, O Perche, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 19, 2026
Feasibility and safety of repeat breast-conserving surgery with intraoperative irradiation for local breast carcinoma recurrences: A phase 2 trialClaire Lemanski, Gilles Houvenaeghel, Sophie Gourgou, et al.
Cancers|February 11, 2023
CANTO-RT: One of the Largest Prospective Multicenter Cohort of Early Breast Cancer Patients Treated with Radiotherapy including Full DICOM RT DataThomas Sarrade, Rodrigue Allodji, Youssef Ghannam, et al.
Human Gene Therapy|March 20, 1997
Use of donor T-lymphocytes expressing herpes-simplex thymidine kinase in allogeneic bone marrow transplantation: a phase I-II studyP Tiberghien, J Y Cahn, A Brion, et al.
Clinical and Translational Radiation Oncology|June 12, 2025
A GORTEC survey on low-risk CTV-P2 delineation in head and neck cancersMichel Lapeyre, Yoann Pointreau, Marc Alfonsi, et al.
The Journal of Rheumatology|August 26, 1998
A randomized, double blind, placebo controlled multicenter trial of murine anti-CD4 monoclonal antibody therapy in rheumatoid arthritisD Wendling, E Racadot, J Wijdenes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 14, 2017
A randomized trial of induction docetaxel-cisplatin-5FU followed by concomitant cisplatin-RT versus concomitant cisplatin-RT in nasopharyngeal carcinoma (GORTEC 2006-02)M Frikha, A Auperin, Y Tao, et al.
Thrombosis Research|February 26, 2010
Clinical characteristics and laboratory testing of patients with suspected HIT: a survey on current practice in 11 university hospitals in FranceAudrey Bidet, Brigitte Tardy Poncet, Dominique Desprez, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 27, 2021
A priori quality assurance using a benchmark case of the randomized phase 2 GORTEC 2014-14 in oligometastatic head and neck cancer patientsN Khalladi, C Dejean, M Bosset, et al.
Pageof 39

Showing results (331-340 of 381) with videos related to

Sort By:
Pageof 39
Clinical and Translational Radiation Oncology|June 17, 2026
Defining physician acceptance of radiosensitivity testing for guiding therapeutic interventions in head and neck cancer: A Delphi consensus studyJuliette Thariat, Arnaud Beddok, Sébastien Salas, et al.
Clinical Nutrition (Edinburgh, Scotland)|July 16, 2013
Immunonutrition improves functional capacities in head and neck and esophageal cancer patients undergoing radiochemotherapy: a randomized clinical trialM-P Vasson, J Talvas, O Perche, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 19, 2026
Feasibility and safety of repeat breast-conserving surgery with intraoperative irradiation for local breast carcinoma recurrences: A phase 2 trialClaire Lemanski, Gilles Houvenaeghel, Sophie Gourgou, et al.
Cancers|February 11, 2023
CANTO-RT: One of the Largest Prospective Multicenter Cohort of Early Breast Cancer Patients Treated with Radiotherapy including Full DICOM RT DataThomas Sarrade, Rodrigue Allodji, Youssef Ghannam, et al.
Human Gene Therapy|March 20, 1997
Use of donor T-lymphocytes expressing herpes-simplex thymidine kinase in allogeneic bone marrow transplantation: a phase I-II studyP Tiberghien, J Y Cahn, A Brion, et al.
Clinical and Translational Radiation Oncology|June 12, 2025
A GORTEC survey on low-risk CTV-P2 delineation in head and neck cancersMichel Lapeyre, Yoann Pointreau, Marc Alfonsi, et al.
The Journal of Rheumatology|August 26, 1998
A randomized, double blind, placebo controlled multicenter trial of murine anti-CD4 monoclonal antibody therapy in rheumatoid arthritisD Wendling, E Racadot, J Wijdenes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 14, 2017
A randomized trial of induction docetaxel-cisplatin-5FU followed by concomitant cisplatin-RT versus concomitant cisplatin-RT in nasopharyngeal carcinoma (GORTEC 2006-02)M Frikha, A Auperin, Y Tao, et al.
Thrombosis Research|February 26, 2010
Clinical characteristics and laboratory testing of patients with suspected HIT: a survey on current practice in 11 university hospitals in FranceAudrey Bidet, Brigitte Tardy Poncet, Dominique Desprez, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 27, 2021
A priori quality assurance using a benchmark case of the randomized phase 2 GORTEC 2014-14 in oligometastatic head and neck cancer patientsN Khalladi, C Dejean, M Bosset, et al.
Pageof 39